Abstract：
This study aimed to assess termination of pregnancy (TOP) indications and obstetric outcomes before the 24th gestational week.
This is a retrospective study that includes terminations performed in singleton pregnancies between December 2021 and December 2022 in the Perinatology Clinic of Necmettin Erbakan University Meram Medical Faculty. According to the reasons for TOP, all patients were divided into three groups: maternal, fetal, and obstetric reasons. The termination approach and outcomes were evaluated in all cases.
A total of 210 patients were included in the study. Considering termination indications, 18 (8.5%) patients had maternal causes, 127 (60.5%) had fetal causes, and 65 (31%) had obstetric causes. Maternal causes were significantly higher in the 1st trimester and fetal causes in the 2nd trimester (P = 0.001). In the maternal group, 77.8% dilatation and curettage were used, 70.1% misoprostol and 29.9% misoprostol + Foley catheter in the fetal group, and 66.2% misoprostol in the obstetric group (P = 0.0001). The length of hospital stay and recurrent revision curettage were not statistically different between the fetal, maternal, and obstetric groups (P = 0.099, P = 0.8, respectively).
Termination options should be offered for complicated pregnancies due to fetal, maternal, or obstetric reasons. Pregnancy termination week and indication affect morbidity.
This is a retrospective study that includes terminations performed in singleton pregnancies between December 2021 and December 2022 in the Perinatology Clinic of Necmettin Erbakan University Meram Medical Faculty. According to the reasons for TOP, all patients were divided into three groups: maternal, fetal, and obstetric reasons. The termination approach and outcomes were evaluated in all cases.
A total of 210 patients were included in the study. Considering termination indications, 18 (8.5%) patients had maternal causes, 127 (60.5%) had fetal causes, and 65 (31%) had obstetric causes. Maternal causes were significantly higher in the 1st trimester and fetal causes in the 2nd trimester (P = 0.001). In the maternal group, 77.8% dilatation and curettage were used, 70.1% misoprostol and 29.9% misoprostol + Foley catheter in the fetal group, and 66.2% misoprostol in the obstetric group (P = 0.0001). The length of hospital stay and recurrent revision curettage were not statistically different between the fetal, maternal, and obstetric groups (P = 0.099, P = 0.8, respectively).
Termination options should be offered for complicated pregnancies due to fetal, maternal, or obstetric reasons. Pregnancy termination week and indication affect morbidity.
摘要：
本研究旨在评估第24孕周前终止妊娠（TOP）的指征和产科结局。
这是一项回顾性研究，包括在2021年12月至2022年12月期间在NecmettinErbakan大学梅兰医学院的围产学诊所进行的单胎妊娠终止。根据TOP的原因，所有患者分为三组：产妇，胎儿,和产科原因。在所有情况下评估终止方法和结果。
本研究共纳入210名患者。考虑到终止指示，18例（8.5%）患者有母亲原因，127（60.5%）有胎儿原因，65（31％）有产科原因。孕前三个月的母体原因明显高于孕前三个月的胎儿原因（P=0.001）。在产妇组中，使用了77.8％的扩张和刮宫术，胎儿组70.1%米索前列醇和29.9%米索前列醇+Foley导尿管,产科组和米索前列醇66.2%(P=0.0001)。住院时间和反复翻修刮宫术在胎儿之间没有统计学差异，母性,和产科组（分别为P=0.099，P=0.8）。
对于因胎儿引起的复杂妊娠，应提供终止妊娠选项，母性,或产科原因。妊娠终止周和适应症影响发病率。
这是一项回顾性研究，包括在2021年12月至2022年12月期间在NecmettinErbakan大学梅兰医学院的围产学诊所进行的单胎妊娠终止。根据TOP的原因，所有患者分为三组：产妇，胎儿,和产科原因。在所有情况下评估终止方法和结果。
本研究共纳入210名患者。考虑到终止指示，18例（8.5%）患者有母亲原因，127（60.5%）有胎儿原因，65（31％）有产科原因。孕前三个月的母体原因明显高于孕前三个月的胎儿原因（P=0.001）。在产妇组中，使用了77.8％的扩张和刮宫术，胎儿组70.1%米索前列醇和29.9%米索前列醇+Foley导尿管,产科组和米索前列醇66.2%(P=0.0001)。住院时间和反复翻修刮宫术在胎儿之间没有统计学差异，母性,和产科组（分别为P=0.099，P=0.8）。
对于因胎儿引起的复杂妊娠，应提供终止妊娠选项，母性,或产科原因。妊娠终止周和适应症影响发病率。
